Zhitong Finance App News, Goli Pharmaceutical-B (01672.HK) issued an announcement. After recently receiving approval from the US Food and Drug Administration (FDA) for clinical trials (IND) of new drugs, it has initiated a US phase I study on ASC36 oral tablets (oral insulin receptor agonist polypeptides) for the treatment of obesity.

Zhitongcaijing · 1d ago
Zhitong Finance App News, Goli Pharmaceutical-B (01672.HK) issued an announcement. After recently receiving approval from the US Food and Drug Administration (FDA) for clinical trials (IND) of new drugs, it has initiated a US phase I study on ASC36 oral tablets (oral insulin receptor agonist polypeptides) for the treatment of obesity.